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parkinsonism in community-dwelling older adults:
a prospective cohort study
Aron S Buchman1,2*, Lei Yu1, Robert S Wilson1,3, Joshua M Shulman4,5, Patricia A Boyle1,3 and David A Bennett1,2Abstract
Background: We tested the hypothesis that harm avoidance, a trait associated with behavioral inhibition, is
associated with the rate of change in parkinsonism in older adults.
Methods: At baseline harm avoidance was assessed with a standard self-report instrument in 969 older people
without dementia participating in the Rush Memory and Aging Project, a longitudinal community-based cohort
study. Parkinsonism was assessed annually with a modified version of the motor section of the Unified Parkinson’s
Disease Rating Scale (mUPDRS).
Results: Average follow-up was 5 years. A linear mixed-effects model controlling for age, sex and education showed
that for an average participant (female, 80 years old at baseline, with 14 years of education and a harm avoidance score
of 10), the overall severity of parkinsonism increased by about 0.05 unit/ year (Estimate, 0.054, S.E., 0.007, p <0.001) and
that the level of harm avoidance was associated with the progression of parkinsonism (Estimate, 0.004, S.E., 0.001,
p <0.001). Thus, for an average participant, every 6 point (~1 SD) increase in harm avoidance score at baseline, the
rate of progression of parkinsonism increased about 50% compared to an individual with an average harm avoidance
score. This amount of change in parkinsonism over the course of the study was associated with about a 5% increased
risk of death. The association between harm avoidance and progression of parkinsonism persisted when controlling
for cognitive function, depressive symptoms, loneliness, neuroticism, late-life cognitive, social and physical activities
and chronic health conditions.
Conclusion: A higher level of the harm avoidance trait is associated with a more rapid progression of parkinsonism
in older adults.
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Late-life parkinsonism including motor slowing (brady-
kinesia), posture and gait disturbances, rigidity and
tremor may be present in up to 50% of community-
dwelling older adults without known neurologic disease
by age of 85 years. Parkinsonism is associated with a
wide range of adverse health outcomes including mor-
bidity, mortality, cognitive decline and dementia [1].
Thus, parkinsonism as part of the spectrum of late-life* Correspondence: Aron_S_Buchman@rush.edu
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reproduction in any medium, provided the ormotor impairment is an important barrier to the main-
tenance of independence and well-being in old age [2].
Identifying risk factors for the progression of parkinson-
ism in older adults is an essential step in efforts to de-
velop interventions which decrease its growing burden.
There is increasing recognition that personality traits
are important determinants of healthy aging. Harm
avoidance is a personality trait indicative of behavioral
inhibition [3]. People with a high level of the trait tend
to be pessimistic, apprehensive, shy, easily fatigued and
risk averse. In prospective studies of children and young
adults, low harm avoidance has been associated with
worse health-related behavior and health outcomes, pos-
sibly because young people with a low level of harmral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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By contrast, in prior works we have shown that in older
people, high harm avoidance is associated with incident
disability and dementia [6,7]. While there is some evi-
dence to suggest that the level of harm avoidance is
related to the level of physical activity, it is not known if
or to what extent this trait is associated with other age-
related conditions such as parkinsonism [8].
To examine the association of harm avoidance and
progression of parkinsonism, we used clinical data from
older adults without dementia participating in the Rush
Memory and Aging Project [9]. Participants completed
a standard self report measure of the trait based on
the Harm Avoidance scale from the Temperament and
Character Inventory [10]. At baseline and at annual in-
tervals thereafter, they had structured evaluations that
included a modified version of the motor section of the
Unified Parkinson Disease Rating Scale (mUPDRS) [9].
We tested the hypothesis that a higher level of the harm
avoidance trait is associated with the rate of progres-
sion of parkinsonism. In further analyses, we examined
whether this association was confounded by cognition,




Participants were recruited from about 40 retirement fa-
cilities and subsidized housing facilities, as well as from
church groups and social service agencies in northeast-
ern Illinois. All participants signed an informed consent
agreeing to annual clinical evaluation. The study was in
accordance with the latest version of the Declaration of
Helsinki and was approved by the Rush University Medical
Center institutional review board [9].
The Memory and Aging Project began in 1997 and the
overall follow-up rate is about 95% of survivors. Because
of the rolling admission and mortality, the length of
follow-up and number of examinations varies across par-
ticipants. Further, because the collection of harm avoid-
ance data was not added until 2004, it was only available
on a subset of Memory and Aging Project participants.
Baseline for these analyses was considered the first cycle
at which harm avoidance was assessed. Eligibility for
these analyses required: 1) a valid assessment of harm
avoidance without evidence of clinical dementia and 2) a
valid measure of parkinsonism at the time harm avoid-
ance was assessed and at least one or more follow-up
evaluations of parkinsonism in order to assess change in
parkinsonism. There were 1,241 participants with harm
avoidance assessment and 63 with evidence of clinical
dementia were excluded. Of the remaining 1178 partici-
pants, there were 209 participants with incomplete par-
kinsonism data who were excluded from these analyses.These included 19 (1.6%) without any parkinsonism data
and 190 (16.1%) who had a single valid assessment of
parkinsonism but did not have a second evaluation ei-
ther because they died before their first follow-up exam-
ination or because they had not been in the study long
enough for follow-up evaluation leaving 969 participants
for these analyses.
Clinical diagnoses
Clinical diagnoses were made using a multi-step process
as previously described [9]. Cognitive function testing
included 19 performance tests were summarized into a
summary measure of global cognition [9]. Participants
were then evaluated in person by an experienced clinician
who diagnosed dementia, stroke, or Parkinson’s disease, or
other neurological and psychiatric disorders based on pub-
lished criteria [11-13].
Assessment of harm avoidance
Study participants completed the 35-items Harm Avoid-
ance scale from the Temperament and Character Inven-
tory assessing harm avoidance, but not the remaining
205 items [3,10]. Items from four subscales were rated as
true or false: anticipatory worry (11 items; e.g., “Things
often go wrong for me unless I’m careful”; range), fear of
uncertainty (7 items; e.g., “I usually feel tense and worried
when I have to do something new and unfamiliar”), shy-
ness (8 items; e.g., “I am more shy than most people”), and
fatigability (9 items; e.g., “I have less energy and tire more
quickly than most people”). The score for the full scale
(range, 0–35) and each subscale is the number of item re-
sponses indicative of the trait in question. These continu-
ous trait measures were used in analyses as described in a
prior study in this cohort [6].
Assessment of parkinsonism
Trained nurse clinicians administered a 26-item modi-
fied motor UPDRS [14]. Four previously established par-
kinsonian sign scores were derived and scaled from 0 to
100 and a global parkinsonian sign score which was con-
structed by averaging these four scores was the primary
outcome measure in these analyses [14].
Assessment of other covariates
Age in years was computed from self-reported date of
birth, and date of the baseline examination. Sex was re-
corded at the baseline interview. Education (reported
highest grade or years of education) was obtained at base-
line testing. Depressive symptoms were assessed with the
Center for Epidemiological Studies Depression Scale, using
a 10-item (e.g., “I felt sad”) version [15]. Loneliness was
assessed with a 5-item (e.g., “I miss having people around”)
form of the deJong-Gierveld Loneliness Scale [16]. The
neuroticism trait was measured with the standard 48-item
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Personality Inventory [17]. BMI was calculated based on
measured weight and height. Chronic health conditions
include 3 vascular risk factors (i.e. hypertension, diabetes
mellitus, and smoking), and 4 vascular diseases (i.e., myo-
cardial infarction, congestive heart failure, claudication
and stroke) [18]. Frequency of participation in cogni-
tively stimulating activities was quantified with a scale,
wherein people rated how often they had participated
in each of 7 cognitive activities (e.g., reading a news-
paper) over the past year [19]. Frequency of participation
in social activity was based on 6 items about activities in-
volving social interaction over the past year [20]. Physical
activity was assessed using questions adapted from the
1985 National Health Interview Survey. Minutes spent en-
gaged in each activity were summed and expressed as
hours of activity/week [21].
Statistical analyses
The global parkinsonian sign score had a positively
skewed distribution and was subjected to a square root
transformation, and the transformed scores were used as
outcome variables in all analyses. We first examined pair-
wise correlations of harm avoidance with several other co-
variates. Then we used a series of linear mixed-effects
models to examine the association of baseline harm avoid-
ance score with the rate of change in severity of parkin-
sonism during the study period [22]. In these models,
repeated measures of square root transformed global par-
kinsonian sign scores were used as the longitudinal out-
come. The primary model predictors included a term for
Time in years since the baseline as well as terms for harm
avoidance at baseline and a term for its interaction with
Time. To control for the effect of demographic variables,
we also included terms for age, sex and education and
their interaction with Time. The model predicted values,
as described in the result section, were derived from the
observed values of the independent variables and the cor-
responding model coefficients and then squared to back-
transform these values to the original scale.
In order to contextualize the association of harm
avoidance with parkinsonism, we centered baseline age,
education, and harm avoidance score, such that all the
model coefficients were interpreted with respect to a
typical participant, that is, a female 80 years old at base-
line, 14 years of education and a harm avoidance score
of 10. Specifically, the coefficient for Time was inter-
preted as the annual rate of change in parkinsonism for
a typical participant with the characteristics mentioned
above. Similarly, the coefficients for harm avoidance and
its interaction with Time estimated the average differ-
ences in baseline parkinsonism and rate of change in
parkinsonism with a 1-point change in baseline harm
avoidance score for a typical participant.In subsequent models, we examined whether other co-
variates might account for the association between harm
avoidance and parkinsonism. Next, we repeated the glo-
bal measure of harm avoidance with trait subscores. To
determine the clinical significance of the amount of
change in the severity of parkinsonism, we first esti-
mated the amount of increase in the rate of progression
of parkinsonism with a 1SD increase in harm avoidance
score, about 6 points, in a mixed effects model. Subse-
quently we constructed Cox proportional hazards models
examining adverse health consequences of change in par-
kinsonism and estimated the hazard ratios associated with
the amount of increase in rate of progression of parkin-
sonism, as given above.. These models controlled for age,
sex and education. Models were examined graphically and
analytically and assumptions were judged to be adequately
met. A priori level of statistical significance was 0.05.
Programming was done in SAS version 9.3 (SAS Institute
Inc, Cary, NC) [23].
Results
Descriptive properties of harm avoidance measure
The clinical characteristics of the participants included
in these analyses at baseline are included in Table 1.
Baseline harm avoidance scores ranged from 0 to 34
with higher values indicating higher level of this trait.
Harm avoidance scores were approximately normally dis-
tributed (mean =10.3; SD = 6.47). Harm avoidance was
higher in women (mean = 10.6; SD = 6.56) versus men
(mean = 9.1; SD = 6.06) [t[923] = 3.14, p = 0.002].
Harm avoidance was associated with neuroticism
(r = 0.50, p < 0.001) depressive symptoms (r = 0.38, p <
0.001), loneliness (r = 0.30, p < 0.001), physical activities
(r = −0.13, p < 0.001), cognitive activities (r = −0.16, p <
0.001) and social activities (r = 0.-0.23, p < 0.001), global
cognition (r = −0.16, p < 0.001), BMI (r = −0.09, p = 0.005)
and vascular diseases (r = 0.06, p < 0.05) but was not asso-
ciated with vascular risk factors (r = 0.044, p = 0.174).
Harm avoidance and change in parkinsonism
Baseline global parkinsonism ranged from 0 to 43
(mean = 7.3; SD = 6.58). We used a linear mixed - effects
model controlled for age, sex, and education to test the
hypothesis that the baseline level of harm avoidance was
associated with the progression of parkinsonism. During
an average follow-up of 5 years (mean = 4.8; SD = 2.59
years), for an average participant (female, 80 years old at
baseline with 14 years of education and a harm avoidance
score of 10) the overall severity of parkinsonism increased
by about 0.05 unit/year (Rate of Change, Table 2). Figure 1
illustrates the heterogeneity of the rate of change in par-
kinsonism for a 25% random sample of the participants in-
cluded in these analyses. Each line in the figure shows the
person-specific change in the rate of parkinsonism during
Table 1 Clinical characteristics of the participants included
in these analyses at this study’s baseline





Global cognition* 0.2 (0.51)








Vascular diseases* 0.4 (0.71)
Myocardial infarction 109 (11.3%)
Congestive heart failure 56 (6.3%)
Claudication 107 (11.0%)
Stroke 102 (11.6%)
Parkinson’s disease 13 (1.4%)
Late-life activities
Physical activity* 3.3 (3.86)
Cognitive activity* 3.2 (0.67)
Social activity* 2.6 (0.58)
*BMI: Body mass index: weight in kilograms divided by height in meters squared.
Global Cognition: composite measure of 19 tests. Depressive Symptoms: Modified
10 item Center for Epidemiological Studies Depression Scale, a higher score
indicates greater depressive symptomatology. Loneliness: Loneliness was assessed
with a 5-item form of the deJong-Gierveld Loneliness Scale. Neuroticism: was
measured with the standard 48-item scale from the NEO Personality Inventory.
Vascular Risk Factors: sum of smoking, diabetes, and hypertension self-reported.
Vascular Diseases: sum of myocardial infarction, congestive heart failure,
claudication and stroke self-reported. Physical Activity: Self-reported frequency of
participation in 5 physical activities (hours/week), a higher score indicates more
frequent participation. Cognitive Activity: Self reported frequency of participation
in 7 cognitive activities, a higher score indicates more frequent participation. Social
Activity: Self-reported frequency of participation in 6 items about activities
involving social interaction, a higher score indicates more frequent participation.
Table 2 A model examining the association of baseline
harm avoidance with the level and annual rate of change
in parkinsonism, adjusting for demographic variables*
Model term Estimate (S.E., p-Value)
Annual rate of change in parkinsonism (Time) 0.054 (0.007, <0.001)
Harm avoidance and level of parkinsonism 0.0216 (0.005,<0.001)
Harm avoidance X annual rate of change in
parkinsonism
0.004 (0.001, <0.001)
Age and level of parkinsonism 0.068 (0.005, <0.001)
Sex and level of parkinsonism −0.098 (0.080,0.221)
Education and level of parkinsonism −0.041 (0.011, <0.001)
Age X annual rate of change in parkinsonism 0.005 (0.001, <0.001)
Sex X annual rate of change in parkinsonism 0.0121 (0.015,0.433)
Education X annual rate of change in
parkinsonism
0.005 (0.002,0.024)
*Based on a linear mixed effect model. The model coefficients are interpreted
with respect to a female participant 80 years old at baseline, with14 years of
education and a harm avoidance score of 10. This model shows the cross
sectional association of an average baseline harm avoidance score with
parkinsonism at baseline as well as the association of the average harm
avoidance score with the annual rate of change in parkinsonism . The model
has a total of 9 terms listed in the left column. It contained a term which show
the annual rate of change of parkinsonism (Time), the cross-sectional association
of in the level of harm avoidance with level of parkinsonism (Harm Avoidance)
and its association with the rate of change in parkinsonism (Harm avoidance X
Rate of change in parkinsonism). In addition, the model also included 6 additional
terms to control for the association of demographic variables (age, sex, education)
with level of parkinsonism and their interaction with the annual rate of change in
parkinsonism. For each term its Estimate (Standard Error, p Value) is shown in the
right column.
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verity of parkinsonism, slope >0, with the remainder exhi-
biting either less severe parkinsonism, (slope <0, (38.0%)
or no change in parkinsonism (2.3%) during the study.
Harm avoidance was associated with both the level of
baseline parkinsonism (Harm Avoidance, Table 2) and
the annual rate of change in parkinsonism (Rate of
Change in Parkinsonism, Table 2). Thus, an average par-
ticipant (female, 80 years old at baseline, with 14 years of
education and a harm avoidance score of 10) had an un-
transformed global parkinsonian score of 6.15 at baseline
and an increase of 0.27 units in their parkinsonian scorefrom study entry to their 1 year follow-up assessment. In
contrast a similar participant whose baseline harm avoid-
ance score was increased by a 6-point (~1 SD), had an
untransformed parkinsonian score of 6.87 at study entry
and an increase 0.42 units during their first year in the
study, a difference of about 1.6 times larger than the typ-
ical participant with the average harm avoidance score.
Since baseline age was also associated with the annual
rate of change in parkinsonism in this model (Table 2),
we can contextualize the annual rate of change in the se-
verity of parkinsonism associated with harm avoidance
by comparing it with the increased severity of parkin-
sonism associated with a more common metric in-
creased age. Comparing their respective coefficients in
this model (Table 2) indicates that a female 80 years old
at baseline with14 years of education and a harm avoid-
ance score of 16 (about 1 SD above the mean) had a rate
of increasing severity of parkinsonism equivalent to a fe-
male 85 years old at baseline, with 14 years of education
and a harm avoidance score of 10. [(6 point increase in
Harm avoidance score × Estimate for harm avoidance
interaction of 0.004)/ Estimate for Age interaction of
0.005) = 4.8 years].
In sensitivity analyses, the association of harm avoid-
ance and the rate of change in parkinsonism remained
significant when we excluded individuals with a history
Figure 1 Person-specific paths of progressive parkinsonism. The figure is organized according to the age of the participant at each
evaluation; the length of each line relative to the x-axis indicates the total years of observation for that individual. The figure is estimated for a
25% random sample of the cohort and shows smoothed person-specific paths estimated from a random-effects model which included a term
for time and controlled for age, sex, education and their interaction with time. The left Y axis shows the square root of global parkinsonian scores
and the right Y axis shows the untransformed global parkinsonian scores.
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1.4%) which might cause more severe parkinsonism
(Stroke: Estimate = 0.006, S.E. = 0.001, p < 0.001); PD:
Estimate = 0.005, S.E. = 0.001, p < 0.001).
The harm avoidance subscores ranges showed sub-
stantial variation: anticipatory worry (range: 0, 11), fear
of uncertainty (range: 0,7), shyness (range: 0,8) and fatig-
ability (range: 0,9). To determine whether the subscores
showed different associations with the rate of change in
parkinsonism, we analyzed each in a separate model.
Higher levels of all four subscores were associated with a
more rapid progression of parkinsonism (Table 3).
Potential confounders of harm avoidance and change in
parkinsonism
Prior work has linked harm avoidance with cognition, we
found that controlling for baseline global cognition, did not
affect the association of harm avoidance and progression of
parkinsonism (Estimate, 0.004, S.E. 0.001, p < 0.001).Table 3 Association of harm avoidance subscores in a typical
in parkinsonism, adjusted for demographic variables*
Harm avoidance
subscore
Annual rate of change in
parkinsonism
Anticipatory worry 0.056 (0.007, <0.001)
Fear of uncertainty 0.058 (0.008, <0.001)
Shyness 0.054 (0.008, <0.001)
Fatigability 0.061 (0.008, <0.001)
*We repeated the model shown in Table 2, four times replacing harm avoidance wit
effect models for a different subscore. The first term is the annual rate of change in
parkinsonism and the 3rd columns shows the relationship between the subscore and
(not shown) which controlled for age, sex, education and their interaction with the rPsychosocial factors can affect late-life motor impair-
ment [16,17]. Therefore we examined whether depres-
sive symptoms, loneliness or the personality trait of
neuroticism might affect the association of harm avoid-
ance and increasing parkinsonism. The association of
harm avoidance with the rate of change in parkinsonism
was not affected when we added terms for depressive
symptoms, loneliness or neuroticism (results not shown).
With all 3 of these correlated covariates in a single model,
the association of harm avoidance and the progression
of parkinsonism remained significant (Estimate = 0.003,
S.E. = 0.001, p = 0.005).
In further analyses, we considered whether chronic
health conditions might have affected our results. Adding
terms for BMI and BMI squared (because both very low
and very high body mass affect health) as well as for vascu-
lar risk factors and vascular diseases, first in separate ana-
lyses (results not shown) and then together in a single
model did not affect the association of harm avoidanceparticipant with the level and the annual rate of change
Subscore & level of
parkinsonism
Subscore X annual rate of
change in parkinsonism
0.039 (0.016, 0.017) 0.009 (0.003,0.005)
0.035 (0.021, 0.163) 0.008 (0.004,0.034)
−0.100 (0.016, 0.51) 0.008 (0.003,0.007)
0.119 (0.014, <0.001) 0.010 (0.003,<0.001)
h each of its 4 subscores. Each row shows the results for a separate linear mixed
parkinsonism; the 2nd term is the relationship between the subscore and level of
the annual rate of change in parkinsonism. Each model also included terms
ate of change in parkinsonism [Estimate (Standard Error, p Value)].
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S.E. = 0.001, p = 0.005).
Since higher levels of late-life activities are associated
with a slower rate of motor decline, [20] we examined
whether the level of a range of different activities might
account for the association of harm avoidance with pro-
gression in parkinsonism. In separate analyses (results
not shown) as well as together, late-life physical, social
and cognitive activities did not affect the association
of harm avoidance and progression of parkinsonism
(Estimate = 0.003, S.E. = 0.001, p = 0.003).
Clinical significance of the loss of motor function
associated with personality
To determine the clinical significance of the more rapid
progression of parkinsonism associated with a 6-point
(about 1 SD) increased harm avoidance score at baseline
(Harm Avoidance X Time, Table 2), we constructed Cox
proportional hazards model examining the association of
change in parkinsonism with death and subsequently es-
timated the hazard ratios associated with the amount of
the increased rate of change in parkinsonism attributable
to a 6-point increase in baseline harm avoidance score
(~1 SD) for an average participant (female 80 years old
with 14 years of education). From these models (data not
shown), we calculated that a 6-point increased harm
avoidance score at baseline for a typical participant was
associated with more than a 5% increased risk of death
over the course of the study (Hazard Ratio: 1.053, 95%
CI: 1.030, 1.077).
Discussion
Harm avoidance is a broad anxiety-related trait. People
with a high level of the trait tend to be pessimistic, ap-
prehensive, shy, and easily fatigued, behaviorally inhib-
ited and to avoid new and potentially aversive situations
[3]. In a cohort of more than 900 older adults, those
with a high level of the trait showed a more rapid rate of
progression of parkinsonism as compared to older adults
with a low level of the trait. This association persisted
after controlling for other psychosocial factors including
depressive symptoms, loneliness and neuroticism, late-
life activities including physical, social and cognitive ac-
tivities, global cognitive function and chronic health
conditions. Together these data suggest that the level of
the trait of harm avoidance, may identify older individ-
uals at higher risk for more rapidly progressive parkin-
sonism and provides evidence for the importance of
personality traits as one of the growing number of fac-
tors which may contribute to healthy aging.
Prior studies have reported that higher levels of harm
avoidance are associated with adverse health conse-
quences in older adults including: incident disability, [6]
and late-life cognitive impairments including incidentmild cognitive impairment (MCI) and Alzheimer’s dis-
ease (AD) as well as cognitive decline [7,24,25]. This
study extends these findings by showing that harm
avoidance is also associated with both the level and rate
of progression of parkinsonism in older adults without
overt neurologic diseases including dementia, stroke and
Parkinson’s disease (PD). Analyses of the sub-scale com-
ponents of harm avoidance showed that all of its constitu-
ent factors are associated with the rate of progressive
parkinsonism. The association of harm avoidance and par-
kinsonism, was robust and remained significant after ac-
counting for related personality traits and psychosocial
factors, global cognition, a wide range of late-life activities
and chronic health conditions. The results of the current
study have important translational implications as they
suggest that personality traits need to be considered for
our understanding of individual differences in the progres-
sion of parkinsonism in older adults. Furthermore, under-
standing the biologic basis of the association has the
potential to lead to new therapeutic targets to reduce the
burden of late-life motor impairment.
The basis of the association between harm avoidance
and parkinsonism is likely to be complex. While, harm
avoidance is related to other personality traits and psy-
chosocial factors, [26] the association of harm avoidance
and parkinsonism was unchanged when we adjusted for
several of these factors in the current study (Table 3)
[27]. Personality traits may affect for lifestyle choices i.e.
physical and other late-life activities and could thus link
harm avoidance with parkinsonism. In contrast to other
personality traits, [17,28] statistical adjustment for late-
life physical, cognitive and social activities in the current
study did not affect the association of harm avoidance
with progressive parkinsonism. Both harm avoidance
and motor function in older people are preferentially as-
sociated with structural changes in specific brain regions
including cortical and cerebellar structures which might
account for their association in this study [29-33]. Thus,
higher levels of harm avoidance may be lead to stress-
related changes in neurotransmitters (e.g., cortisol or
dopamine) causing brain atrophy, damaging motor-related
brain regions or decreasing the brain’s capacity (motor
reserve) to tolerate ongoing neurodegeneration and the ac-
cumulation of other neuropathologies [34-37].
Over the years there have been many reports suggest-
ing that PD may be associated with a distinctive person-
ality which may manifest many years before clinical
evidence of parkinsonism, but empirical studies have
failed to support this suggestion [38,39]. Nonethelss,
building on imaging data linking harm avoidance with
brain dopamine receptors, recent studies have reported
higher levels of harm avoidance occur in individuals
with early clinical manifestations of PD such as REM
sleep disorder which can manifest years before a clinical
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have suggested that PD pathology is found in up to 40%
of older adults without a clinical diagnoses of PD, and
these lesions are associated with the severity of parkin-
sonism proximate to death [14]. Further work is needed
to determine if the accumulation of subclinical PD path-
ology might contribute to the association between harm
avoidance and the rate of change in the severity of par-
kinsonism. Alternatively, lower harm avoidance is associ-
ated with resilience, optimism, composure, and energy
which may facilitate adaptation to accumulating neuro-
degeneration and the accumulation of neuropathology in
older adults [10,44]. Further work to understand the
neurobiologic basis for the current findings has the po-
tential to identify new targets and pathways, for inter-
ventions to decrease the growing burden of progressive
parkinsonism in older adults.
Our study has some limitations. While some studies
have suggested that personality traits such as harm
avoidance are stable even in old age, others suggest that
personality changes may occur with age but there are
few studies which have focused on individuals older than
80 years [45-48]. Further, it is possible that a third un-
measured variable is related to both harm avoidance and
progressive parkinsonism. A precondition for participa-
tion in the current study was consent to annual exam
and organ donation at death, so given the selected na-
ture of the cohort, our findings will need replication in
other cohorts. This study was large since on an individ-
ual level the effect sizes for the association of harm
avoidance and progressive parkinsonism are small. Simi-
lar effect sizes have been reported in prior reports of
other psychosocial factors with motor decline [17].
Nonetheless, from a public policy perspective even the
modest effect sizes observed in the current study are
likely to be important.
However, several factors increase confidence in our
findings. Perhaps most importantly, the study enjoys
high follow-up participation reducing bias due to attri-
tion. In addition, personality traits were assessed among
people without dementia and parkinsonism was evalu-
ated as part of a uniform clinical evaluation which incor-
porated other widely accepted personality, affect and
cognitive measures. In addition, a relatively large num-
ber of older people were studied, so that there was
adequate statistical power to identify the association of
interest while controlling for several potentially con-
founding variables. Results were similar with total score
and subscores of the trait of harm avoidance.
Conclusions
The growing personal and social burden of late-life
motor impairment in our aging population is a public
health challenge. In a cohort of nearly 1000 older adults,individuals with a higher level of the trait of harm avoid-
ance showed a more rapid rate of progressive parkinson-
ism as compared to older adults with a low level of the
trait. The results of the current study suggest that the
level of the trait of harm avoidance may identify older
adults at higher risk for more rapid motor decline and
underscore that personality traits need to be considered
in studies of individual differences of late-life motor
impairments. Finally, this study provides additional evi-
dence for the importance of personality traits as one of
the growing number of factors which may contribute to
healthy aging.
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